Iradimed (IRMD) Capital Expenditures Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.95% |
| Dec 31, 2025 | -112.97% |
| Sep 30, 2025 | 87.78% |
| Jun 30, 2025 | 81.47% |
| Mar 31, 2025 | 85.88% |
| Dec 31, 2024 | 106.33% |
| Sep 30, 2024 | 128.97% |
| Jun 30, 2024 | -7.70% |
| Mar 31, 2024 | 94.48% |
| Dec 31, 2023 | 23.59% |
| Sep 30, 2023 | -1.89% |
| Jun 30, 2023 | -295.87% |
| Mar 31, 2023 | 635.08% |
| Dec 31, 2022 | -22.15% |
| Sep 30, 2022 | 88.53% |
| Jun 30, 2022 | 83.34% |
| Mar 31, 2022 | 340.14% |
| Dec 31, 2021 | -20.72% |
| Sep 30, 2021 | 56.94% |
| Jun 30, 2021 | -17.17% |
| Mar 31, 2021 | -14.50% |
| Dec 31, 2020 | -20.54% |
| Sep 30, 2020 | 19.63% |
| Jun 30, 2020 | 10.55% |
| Mar 31, 2020 | 32.83% |
| Dec 31, 2019 | -24.51% |
| Sep 30, 2019 | -30.77% |
| Jun 30, 2019 | 52.18% |
| Mar 31, 2019 | 17.77% |
| Dec 31, 2018 | -36.39% |
| Sep 30, 2018 | 11.66% |